Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G T Griffing

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
The Journal of Clinical Endocrinology and Metabolism|December 1, 1994
A-I-D-S: the new endocrine epidemicG T Griffing
The Journal of Clinical Endocrinology and Metabolism|March 1, 1995
21-deoxyaldosteronism: a new clinical syndromeG T Griffing
The Journal of Clinical Endocrinology and Metabolism|December 1, 1993
Dinosaurs and steroidsG T Griffing
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1983
The therapeutic use of a new potassium-sparing diuretic, amiloride, and a converting enzyme inhibitor, MK-421, in preventing hypokalemia associated with primary and secondary hyperaldosteronismG T Griffing, J C Melby
Journal of Clinical Pharmacology|July 1, 1985
Adrenocortical factors in hypertensionG T Griffing, J C Melby
Metabolism: Clinical and Experimental|April 1, 1989
Reversal of diuretic-induced secondary hyperaldosteronism and hypokalemia by trilostane, an inhibitor of adrenal steroidogenesisG T Griffing, J C Melby
Postgraduate Medicine|October 1, 1994
Estrogen replacement therapy at menopause. How benefits outweigh risksG T Griffing, S H Allen
Lancet (London, England)|June 12, 1982
Enalapril (MK-421) and the white cell count and haematocritG T Griffing, J C Melby
Hospital Practice (Office Ed.)|May 30, 1991
Hirsutism causes and treatmentsG T Griffing, J C Melby
Journal of Clinical Hypertension|September 1, 1985
The therapeutic effect of a new angiotensin-converting enzyme inhibitor, enalapril maleate, in idiopathic hyperaldosteronismG T Griffing, J C Melby
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
The Journal of Clinical Endocrinology and Metabolism|December 1, 1994
A-I-D-S: the new endocrine epidemicG T Griffing
The Journal of Clinical Endocrinology and Metabolism|March 1, 1995
21-deoxyaldosteronism: a new clinical syndromeG T Griffing
The Journal of Clinical Endocrinology and Metabolism|December 1, 1993
Dinosaurs and steroidsG T Griffing
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1983
The therapeutic use of a new potassium-sparing diuretic, amiloride, and a converting enzyme inhibitor, MK-421, in preventing hypokalemia associated with primary and secondary hyperaldosteronismG T Griffing, J C Melby
Journal of Clinical Pharmacology|July 1, 1985
Adrenocortical factors in hypertensionG T Griffing, J C Melby
Metabolism: Clinical and Experimental|April 1, 1989
Reversal of diuretic-induced secondary hyperaldosteronism and hypokalemia by trilostane, an inhibitor of adrenal steroidogenesisG T Griffing, J C Melby
Postgraduate Medicine|October 1, 1994
Estrogen replacement therapy at menopause. How benefits outweigh risksG T Griffing, S H Allen
Lancet (London, England)|June 12, 1982
Enalapril (MK-421) and the white cell count and haematocritG T Griffing, J C Melby
Hospital Practice (Office Ed.)|May 30, 1991
Hirsutism causes and treatmentsG T Griffing, J C Melby
Journal of Clinical Hypertension|September 1, 1985
The therapeutic effect of a new angiotensin-converting enzyme inhibitor, enalapril maleate, in idiopathic hyperaldosteronismG T Griffing, J C Melby
Pageof 6